Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif
Author
Molinos-Albert, Luis M.
Bilbao, Eneritz
Agulló, Luis
Marfil, Silvia
García, Elisabet
Rodríguez de la Concepción, Maria Luisa
Izquierdo-Useros, Nuria
Vilaplana, Cristina
Nieto-Garai, Jon A.
Contreras, F. Xabier
Cardona, Pere J.
Martinez-Picado, Javier
Clotet, Bonaventura
Lorizate, Maier
Carrillo, Jorge
Blanco, Julià
Publication date
2017-01-13ISSN
2045-2322
Document Type
Article
Document version
Accepted version
Language
English
Subject (CDU)
61 - Medical sciences
Keywords
Infeccions per VIH
Lípids
Immunodeficiència
Immunoglobulines
Antígens
Infecciones por VIH
Lípidos
Inmunodeficiencia
Inmunoglobulinas
Antígenos
HIV infections
Lipids
Immunodeficiency
Immunoglobulins
Antigens
Pages
15
Publisher
Springer Nature
Collection
7;
Is part of
Scientific Reports
Citation
Molinos-Albert, Luis M.; Bilbao, Eneritz; Agulló, Luis [et al.]. Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif. Scientific Reports, vol. 7, e40800. Disponible en: <https://www.nature.com/articles/srep40800#Ack1>. Fecha de acceso: 7 mar. 2020. DOI: 10.1038/srep40800
Grant agreement number
info:eu-repo/grantAgreement/ES/3PN/BFU2012-33103
info:eu-repo/grantAgreement/ES/1PE/SAF2013-49042-R
This item appears in the following Collection(s)
- Ciències de la Salut [740]
Rights
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/